The regulatory T (Treg) cells accumulating in the TIME of glioma could inhibit immune surveillance and attack by excreting IL-10, IL-35 and TGF-β, which possibly predicts the poor prognosis of patients with gliomas [131,132,133]. This evidence concerns the gene TGFB1 and central nervous system cancer.